[go: up one dir, main page]

PE129299A1 - Metodo para la sintesis de derivados de quinolina - Google Patents

Metodo para la sintesis de derivados de quinolina

Info

Publication number
PE129299A1
PE129299A1 PE1998000868A PE00086898A PE129299A1 PE 129299 A1 PE129299 A1 PE 129299A1 PE 1998000868 A PE1998000868 A PE 1998000868A PE 00086898 A PE00086898 A PE 00086898A PE 129299 A1 PE129299 A1 PE 129299A1
Authority
PE
Peru
Prior art keywords
alkyl
compound
aryl
formula
cyclloalkyl
Prior art date
Application number
PE1998000868A
Other languages
English (en)
Inventor
Joseph Sisko
Mark Mellinger
Conrad Kowalski
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PE129299A1 publication Critical patent/PE129299A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO DE FORMULA I, DONDE Ar ES FENILO OPCIONALMENTE SUSTITUIDO, NAFTILO, CICLOALCADIENILO C5-C7, HETEROCICLO AROMATICO DE 1-2 ANILLOS, DE 5 A 12 MIEMBROS; R ES ALQUILO C1-C8, CICLOALQUILO C3-C7, CICLOALQUILALQUILO C4-C7, FENIL, FENIL-ALQUILO C1-C6, ENTRE OTROS; R1 Y R2 SON H, ALQUILO C1-C6, O JUNTOS FORMAN -(CH2)n; O R1 JUNTO A R FORMA -(CH2)q-; n ES 3-5; q ES 2-5; R3 Y R4 SON H, ALQUILO C1-C6, ALQUENILO C1-C6, ARILO, -O(CH2)r-NT2, ENTRE OTROS; r ES 2-4, T ES ALQUILO C1-C6, GRUPO b o c; V Y V1 SON H; u ES 0-2 o R4 ES -(CH2)t- CUANDO R5 ES ARILO; t ES 1-3; R5 ES ALQUILO C1-C6, CICLOALQUILO C3-C7, CICLOALQUILALQUILO C4-C7, ARILO, ENTRE OTROS; EL PROCESO COMPRENDE a)ANADIR UN COMPUESTO DE FORMULA III A UNA BASE EN UN DISOLVENTE ADECUADO, LUEGO ANADIR R5-C(=O)-CH2-R4; Y CALENTAR PARA FORMAR UN COMPUESTO DE FORMULA IV; b)AISLAR EL COMPUESTO (IV), Y REACCIONAR CON UNA BASE, ENFRIAR; c)ANADIR UN AGENTE ACTIVANTE DE CARBONILO, d)ANADIR (R2)(H)N-C(R)(R1)(Ar); CALENTAR. UN COMPUESTO PREFERIDO ES LA SAL DE HIDROCLORURO (-)-(S)-N-(O-ETILBENCIL)-3-HIDROXI-2-FENILQUINOLINA-4-CARBOXAMIDA
PE1998000868A 1997-09-17 1998-09-11 Metodo para la sintesis de derivados de quinolina PE129299A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5930397P 1997-09-17 1997-09-17

Publications (1)

Publication Number Publication Date
PE129299A1 true PE129299A1 (es) 2000-02-19

Family

ID=22022126

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000868A PE129299A1 (es) 1997-09-17 1998-09-11 Metodo para la sintesis de derivados de quinolina

Country Status (32)

Country Link
US (6) US6335448B1 (es)
EP (1) EP1017676B1 (es)
JP (1) JP2001516744A (es)
KR (1) KR20010024031A (es)
CN (1) CN1125815C (es)
AP (1) AP1201A (es)
AR (1) AR015445A1 (es)
AT (1) ATE353879T1 (es)
AU (1) AU744538B2 (es)
BG (1) BG104243A (es)
BR (1) BR9812085A (es)
CA (1) CA2303026A1 (es)
DE (1) DE69837100T2 (es)
DZ (1) DZ2607A1 (es)
EA (1) EA002633B1 (es)
ES (1) ES2283072T3 (es)
HU (1) HUP0004855A3 (es)
ID (1) ID24140A (es)
IL (1) IL134991A0 (es)
MA (1) MA24644A1 (es)
MY (1) MY120237A (es)
NO (1) NO314303B1 (es)
NZ (1) NZ503307A (es)
OA (1) OA11340A (es)
PE (1) PE129299A1 (es)
PL (1) PL339340A1 (es)
SK (1) SK3672000A3 (es)
TR (1) TR200000720T2 (es)
TW (1) TW509678B (es)
UY (2) UY25174A1 (es)
WO (1) WO1999014196A1 (es)
ZA (1) ZA988455B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.
CA2368455A1 (en) 1999-03-29 2000-10-05 Neurogen Corporation 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
WO2005080373A1 (en) 2004-02-04 2005-09-01 Pfizer Products Inc. Substituted quinoline compounds
CN101189211A (zh) * 2005-06-03 2008-05-28 阿斯利康(瑞典)有限公司 作为nk3拮抗剂的喹啉衍生物
US20080194623A1 (en) * 2005-08-02 2008-08-14 Labaw Clifford S Method for the Synthesis of Quinoline Derivatives
US20080280949A1 (en) * 2005-08-11 2008-11-13 Astrazeneca Ab Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators
AR057130A1 (es) * 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
US20080234269A1 (en) * 2005-09-21 2008-09-25 Astrazeneca Ab N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands
JP2009524656A (ja) * 2006-01-27 2009-07-02 アストラゼネカ・アクチエボラーグ アミド置換キノリン
CN102924375B (zh) * 2012-06-21 2015-02-18 江苏恩华药业股份有限公司 Talnetant中间体及其制备方法和应用
CN102702099A (zh) * 2012-06-21 2012-10-03 江苏恩华药业股份有限公司 (s)-3-羟基-2-苯基-n-(1-苯基丙基)喹啉-4-甲酰胺的制备方法
CN103214416A (zh) * 2013-04-26 2013-07-24 扬州大学 一种合成多取代喹啉类化合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776290A (en) * 1957-01-01 Hydroxy cevchoninates and carboxylic
AU699319B2 (en) * 1994-05-27 1998-12-03 Smithkline Beecham Farmaceutici S.P.A. Quinoline derivatives as tachykinin nk3 receptor antagonists
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.

Also Published As

Publication number Publication date
CN1125815C (zh) 2003-10-29
BG104243A (en) 2001-05-31
MA24644A1 (fr) 1999-04-01
EA200000322A1 (ru) 2000-10-30
CN1278796A (zh) 2001-01-03
PL339340A1 (en) 2000-12-18
ATE353879T1 (de) 2007-03-15
DE69837100D1 (de) 2007-03-29
IL134991A0 (en) 2001-05-20
US20050171152A1 (en) 2005-08-04
HUP0004855A2 (hu) 2001-06-28
EP1017676A1 (en) 2000-07-12
WO1999014196A1 (en) 1999-03-25
DZ2607A1 (fr) 2003-03-01
AU9395898A (en) 1999-04-05
EP1017676B1 (en) 2007-02-14
US20020173657A1 (en) 2002-11-21
AP2000001767A0 (en) 2000-03-31
NO314303B1 (no) 2003-03-03
US20060189809A1 (en) 2006-08-24
BR9812085A (pt) 2000-09-26
EA002633B1 (ru) 2002-08-29
US6335448B1 (en) 2002-01-01
HUP0004855A3 (en) 2001-08-28
SK3672000A3 (en) 2000-09-12
CA2303026A1 (en) 1999-03-25
ID24140A (id) 2000-07-06
AP1201A (en) 2003-09-01
UY25407A1 (es) 1999-11-17
AR015445A1 (es) 2001-05-02
TR200000720T2 (tr) 2000-08-21
AU744538B2 (en) 2002-02-28
KR20010024031A (ko) 2001-03-26
UY25174A1 (es) 2001-07-31
EP1017676A4 (en) 2002-12-04
US20040049031A1 (en) 2004-03-11
US20020038029A1 (en) 2002-03-28
TW509678B (en) 2002-11-11
NO20001387L (no) 2000-03-16
ZA988455B (en) 1999-02-17
ES2283072T3 (es) 2007-10-16
JP2001516744A (ja) 2001-10-02
DE69837100T2 (de) 2007-11-22
NO20001387D0 (no) 2000-03-16
MY120237A (en) 2005-09-30
OA11340A (en) 2003-12-09
NZ503307A (en) 2002-04-26

Similar Documents

Publication Publication Date Title
AR046938A1 (es) Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
PE129299A1 (es) Metodo para la sintesis de derivados de quinolina
UA41254C2 (uk) ПОХІДНЕ ТЕТРАГІДРОКАРБАЗОЛУ АБО ЙОГО СІЛЬ, СОЛЬВАТ АБО ГІДРАТ ЯК АГОНІСТ 5-НТ<sub>1</sub>-ПОДІБНОГО РЕЦЕПТОРА, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ
AR037489A1 (es) Quinolinas sustituidas y proceso para su preparacion
AR010376A1 (es) Compuestos con efecto analgesico, su uso para la fabricacion de medicamentos, agentes de diagnostico, composicion farmaceutica, procedimiento para la preparacion de dichos compuestos y compuestos intermediarios
IS4681A (is) 8-azabísýkló(3.2.1)okt-2-en afleiður, framleiðslaþeirra og notkun
UA49872C2 (uk) Похідні тропану, спосіб їх одержання, фармацевтична композиція та спосіб лікування
AR010378A1 (es) Novedosos compuestos con efecto analgesico, uso de los mismos para la preparacion de un medicamento y como agente de diagnostico, composicion farmaceutica, proceso para la preparacion de dichos compuestos y compuestos intermediarios
SE9702799D0 (sv) New compounds
KR910006218A (ko) 2-아미도테트라린 치환유도체와 이 치환유도체를 포함하는 제약학적 조성물 및 이를 사용한 치료방법
YU40998A (sh) Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
SE0101579D0 (sv) New compounds
HUP0302157A2 (hu) 4-(2-Fenil-tiazol-5-il)-1,4-diazabiciklo[3.2.2]nonán-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
KR960703864A (ko) 신규한 축합 인단 유도체 및 그의 약학적으로 허용가능한 염(novel fused indan derivative and pharmaceutically acceptable salt thereof)
KR890006590A (ko) 4-아미노피리딘 유도체
ECSP930953A (es) Nuevos derivados de indol
KR880001650A (ko) 트리아졸로피리딘 또는 트리아졸로퀴놀린의 신규 아미노알킬티오 유도체, 그의 제조방법 및 특히 진통제로서 유용한 그것이 존재하는 약제
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
AR072336A1 (es) Derivados de la 3-carboxipropil-aminotetralina, composiciones farmaceuticas que los contienen, procedimiento para su preparacion, intermediarios y su procedimiento de preparacion
DK0461958T3 (da) 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien
BR9606985A (pt) Processo para preparar um composto
AR038342A1 (es) Derivados piridin-amido
AR034861A1 (es) Un compuesto de indenoindolona, un procedimiento para su preparacion y una composicion farmaceutica que lo comprende
KR920004402A (ko) 신규 퀴놀린 카르복실산 유도체, 상기 화합물 함유 항균제 및 상기 화합물 제조 방법
SE9002727D0 (sv) Novel cyclic ketone derivatives and pharmaceuticalcompositions containing same as well as a process for their preparation

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed